Citation only
via OpenAlex
Metformin as a Senotherapeutic Agent
Şeydanur Turgut, Erdem Atasever, Gülnur Andican, Ufuk Çakatay
Healthy ageing and longevity · 2026
Abstract
This 2026 article in Healthy ageing and longevity examines the role of metformin as a senotherapeutic agent. It reviews current research on the compound.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/978-3-032-11608-6_16
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Turgut, �., Atasever, E., Andican, G., & Çakatay, U. (2026). Metformin as a Senotherapeutic Agent. <em>Healthy ageing and longevity</em>. https://doi.org/10.1007/978-3-032-11608-6_16
Vancouver
Turgut �, Atasever E, Andican G, Çakatay U. Metformin as a Senotherapeutic Agent. Healthy ageing and longevity. 2026. doi:10.1007/978-3-032-11608-6_16.
BibTeX
@article{eydanur2026Metfor,
title = {Metformin as a Senotherapeutic Agent},
author = {Şeydanur Turgut and Erdem Atasever and Gülnur Andican and Ufuk Çakatay},
journal = {Healthy ageing and longevity},
year = {2026},
doi = {10.1007/978-3-032-11608-6_16},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brain Behavior and Immunity 2019
Citation only
Abstract # 3179 The interaction of benefit finding and behavioral disengagement in predicting inflammatory biomarkers
Clinical Therapeutics 2019
Open access · OA
Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention
Reproductive Sciences 2015
Preprint · OA
Visfatin/Nampt and SIRT1
Biogerontology 2022
Citation only
Mitochondria-targeted senotherapeutic interventions
Cell Metabolism 2013
Open access · OA
Metformin, Microbes, and Aging
Healthy ageing and longevity 2019
Citation only